Keywords: exonhit, allergan, extend, accord, french, diagnostics, firm
ExonHit and Allergan extend R&D accord
Article | 12 January 2009
French diagnostics firm ExonHit Therapeutics has extended its existing drug discovery collaboration with Allergan Sales until December 2011. The accord includes ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
